XTL BIOPHARMACEUTICALS LTD. Weighted Average Shares
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Weighted Average Shares of 673.04 million shares for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Income Statement › Earnings Per Share
ifrs-full:WeightedAverageShares · last filed 2025-04-30
- XTL BIOPHARMACEUTICALS LTD. weighted average shares for the quarter ending 2022-06-30 was 544.91M shares, a 3.24% increase year-over-year.
- XTL BIOPHARMACEUTICALS LTD. weighted average shares for the quarter ending 2021-06-30 was 527.79M shares, a 2.64% increase year-over-year.
- XTL BIOPHARMACEUTICALS LTD. weighted average shares for the quarter ending 2020-06-30 was 514.21M shares.
| Period end | Weighted Average Shares 3 month | Weighted Average Shares 6 month | Weighted Average Shares 12 month |
|---|---|---|---|
| 2024-12-31 | 673.04M shares 20-F · filed 2025-04-30 | ||
| 2023-12-31 | 544.91M shares 20-F · filed 2025-04-30 | ||
| 2022-12-31 | 544.91M shares 20-F · filed 2025-04-30 | ||
| 2022-06-30 | 544.91M shares 6-K · filed 2022-08-24 | 544.91M shares 6-K · filed 2022-08-24 | |
| 2021-12-31 | 532.00M shares 20-F · filed 2023-03-22 | ||
| 2021-06-30 | 527.79M shares 6-K · filed 2022-08-24 | 522.76M shares 6-K · filed 2022-08-24 | |
| 2020-12-31 | 514.21M shares 20-F · filed 2023-03-22 | ||
| 2020-06-30 | 514.21M shares 6-K · filed 2021-08-24 | 514.21M shares 6-K · filed 2021-08-24 | |
| 2019-12-31 | 514.21M shares 20-F · filed 2022-03-30 | ||
| 2018-12-31 | 514.21M shares 20-F/A · filed 2021-05-19 | ||
| 2017-12-31 | 470.19M shares 20-F · filed 2020-03-12 | ||
| 2016-12-31 | 274.04M shares 20-F · filed 2019-03-11 | ||
| 2015-12-31 | 263.73M shares 20-F · filed 2018-03-15 |